| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850422 | American Heart Journal | 2010 | 11 Pages |
Abstract
The REVEAL trial will evaluate the safety and efficacy of the highest tolerated single dose of epoetin α in patients who have undergone successful rescue or primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chiara MD, MHS, Sunil V. MD, Thomas J. MD, Laura PhD, Raymond J. MD, Rakhi MS, Manesh R. MD, Mark MD, PhD, Luigi MD, PhD, Dan L. MD, Edward G. MD, Samer S. MD, Robert A. MD,